Australian technology innovator Nanoveu Limited has received an order from its distributor for Thailand and Malaysia to supply over A$125,000 of non-woven polypropylene fabric incorporating its antiviral technology.
Nanoveu said the newly developed material will be used to manufacture antiviral face masks interwoven with its Nanoshield antiviral and antibacterial technology, which has been tested extensively across the US, Japan, Singapore, India, China, Europe and Dubai.
Nanoveu’s antiviral technology has been proven to eliminate 99.99% of SARS-CoV-2 (COVID-19) and HCoV-299E, OC43, another coronavirus affecting humans in 30 minutes.
According to a statement from the company, “Nanoveu’s antiviral technology has been independently demonstrated to be a highly effective agent for the inactivation of viruses and bacteria. The technology has been proven to eliminate 99.99% of SARS-CoV-2 (COVID-19) and HCoV-299E, OC43, another coronavirus affecting humans in 30 minutes.”
Alfred Chong, Founder, Executive Director and CEO of Nanoveau, said the company was delighted to continue its work within Australia providing successful solutions against viral diseases.
“The continued global support for the masks validates the superiority and efficacy of Nanoveau’s Nanoshield,” Mr Chong continued.
“With reinstated lockdowns across Australia, businesses are in severe need of solutions to address the challenges of living with COVID-19 and we believe Nanoshield can aid Australian citizens and businesses in returning to normal working and living environments.
“Nanoshield’s status has been recognised as a globally significant product and from an international standpoint we believe there are a considerable number of countries that can be engaged, positively impacting patient health outcomes and assisting in fighting various strains of viruses.”